ReviewCNS drugs2026
Pathological Protein Targets in Parkinson's Disease: Progress Towards the Development of Disease-Modifying Therapies.
Nicolas DzamkoPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it